Scarica l'app Stockscreener
308.05
0.16%
-0.48
Dopo l'orario di chiusura:
309.10
1.05
+0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$308.53
Aprire:
$308
Volume 24 ore:
139.86K
Relative Volume:
0.66
Capitalizzazione di mercato:
$8.31B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-11.27
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-3.30%
1M Prestazione:
+0.81%
6M Prestazione:
+36.57%
1 anno Prestazione:
-10.87%
Intervallo 1D:
$307.35
$312.98
Intervallo di 1 settimana:
$307.35
$325.33
Portata 52W:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
308.05 | 8.32B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
121.25 | 212.30B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.53 | 139.11B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
349.23 | 135.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.62 | 129.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.28 | 48.93B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Polymerase Chain Reaction (PCR) Market Rapid Growt 2025-2033: - openPR.com
Why (BIO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
What is the fair value estimate for Bio Rad Laboratories Inc. (BUW) stock in 2025Market Sentiment Summary & High Conviction Buy Zone Picks - Newser
What insider purchases suggest about Bio Rad Laboratories Inc. Class stockEarnings Miss & Low Risk High Reward Ideas - Newser
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikesJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buyJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - Newser
Is Bio Rad Laboratories Inc. Class B stock a good hedge against inflationWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Why Bio Rad Laboratories Inc. (BUW) stock could break out in 2025Analyst Upgrade & Stock Market Timing Techniques - Newser
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSys - pharmiweb.com
Will Bio Rad Laboratories Inc. (BUWA) stock recover faster than industryTrade Entry Summary & Long-Term Safe Return Strategies - Newser
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsGap Down & Weekly Watchlist for Hot Stocks - Newser
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and MoreResearchAndMarkets.com - The AI Journal
Can Bio Rad Laboratories Inc. Class stock expand revenue streams2025 Year in Review & Weekly Top Gainers Alerts - Newser
How geopolitical risks impact Bio Rad Laboratories Inc. (BUWA) stockTrade Exit Report & Consistent Profit Trading Strategies - Newser
Why Bio Rad Laboratories Inc. stock is in analyst buy zoneEarnings Overview Summary & Low Risk High Reward Ideas - Newser
Will Bio Rad Laboratories Inc. (BUW) stock outperform energy sector in 2025Share Buyback & Free Weekly Watchlist of Top Performers - Newser
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch tickerEntry Point & Long-Term Capital Growth Strategies - Newser
Will Bio Rad Laboratories Inc. (BUW) stock recover faster than industry - Newser
Can Bio Rad Laboratories Inc. (BUWA) stock resist broad market declinesJuly 2025 Update & Weekly Stock Breakout Alerts - Newser
Circulating Biomarkers Market Projections 2025-2032: Key - openPR.com
Next Generation Sequencing Library Preparation Market - openPR.com
Hydroxyapatite Market Size, Scope 2031 by Key Companies- Zimmer - openPR.com
Fisher Asset Management LLC Sells 5,884 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Will Bio Rad Laboratories Inc. Class B stock announce special dividendNew Guidance & Verified Trade Idea Suggestions - Newser
What earnings margins imply for Bio Rad Laboratories Inc. Class B stockMarket Risk Report & Verified Technical Trade Signals - Newser
Bio-Rad Laboratories (NYSE: BIO) insider files to sell 776 shares under Rule 144 - Stock Titan
Bio-Rad Laboratories, Inc. $BIO Position Trimmed by Legal & General Group Plc - MarketBeat
Rhumbline Advisers Has $12.10 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Why analysts maintain buy rating on Bio Rad Laboratories Inc. (BUW) stockJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - Newser
Is Bio Rad Laboratories Inc. Class stock undervalued by metrics2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
Will Bio Rad Laboratories Inc. Class stock rise with strong economyWeekly Stock Analysis & Low Risk Profit Maximizing Plans - Newser
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Capital Fund Management S.A. Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Will Bio Rad Laboratories Inc. (BUW) stock benefit from infrastructure bill2025 Momentum Check & Stock Portfolio Risk Management - Newser
Will Bio Rad Laboratories Inc. stock return to pre crisis levelsTrade Entry Summary & Entry Point Strategy Guides - Newser
Published on: 2025-12-02 01:11:23 - Newser
Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile? - MSN
How Bio Rad Laboratories Inc. (BUWA) stock stacks up against competitors2025 Retail Activity & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-12-01 23:20:24 - Newser
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts - Yahoo! Finance Canada
Swiss National Bank Lowers Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Bought by Franklin Resources Inc. - MarketBeat
Will Bio Rad Laboratories Inc. stock outperform growth indexesJuly 2025 Movers & Daily Volume Surge Trade Alerts - moha.gov.vn
Published on: 2025-11-27 20:53:42 - BỘ NỘI VỤ
Laboratory Proficiency Testing Market- By Type LGC Limited - openPR.com
Understanding Momentum Shifts in (BIO) - news.stocktradersdaily.com
CapEx per share of Bio-Rad Laboratories, Inc. Class A – LS:865406 - TradingView
US STD Diagnostics Market Forecast and Company Analysis - GlobeNewswire
US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad - Yahoo Finance
Chromatography Accessories and Consumables Market Size, - openPR.com
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.67%
1.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):